Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data
Anika Singh, Ashwin Kamath
Abstract
Our study confirms the drug label information regarding liver enzyme elevation. The renal and cardiac safety signals identified necessitate reevaluation for potential drug-labeling changes.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Adverse effectCoronavirusDiseasePandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakIntensive care medicineClinical trialMedical emergencyEmergency medicineInternal medicineVirologyInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesPharmacovigilance and Adverse Drug ReactionsSARS-CoV-2 and COVID-19 Research